Parkinson’s Disease and rTMS: Discover how repetitive Transcranial Magnetic Stimulation (rTMS) is offering new hope beyond medication for Pa
Parkinson’s Disease and rTMS — Stimulating Hope Beyond Medication. Parkinson’s disease (PD) is the world’s fastest-growing neurological disorder, affecting over 10 million people globally, with India accounting for more than 580,000 cases. For decades, levodopa has remained the cornerstone of Parkinson’s management, helping restore near-normal motor function during the early stages of the disease. However, as Parkinson’s progresses, the limitations of medication become increasingly evident, with patients experiencing motor fluctuations, dyskinesias, freezing of gait, and several non-motor symptoms that conventional dopaminergic therapy cannot fully address. This is where repetitive Transcranial Magnetic Stimulation (rTMS) is emerging as a promising, non-invasive treatment option, offering renewed hope beyond medication.
Learn how Dr. (Prof.) Kunal Bahrani, known for advanced neurological care and expert rTMS therapy in Delhi NCR, is helping patients improve their quality of life with cutting-edge brain stimulation treatment.

















